Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The critical role of inflammation in atherosclerotic coronary artery heart disease.

Current problems in cardiology·2026
Same author

The diagnosis and treatment of asymptomatic and symptomatic patients with carotid artery stenosis.

Current problems in cardiology·2025
Same author

Sleep apnea is a common and dangerous cardiovascular risk factor.

Current problems in cardiology·2024
Same author

The differentiation of the competitive athlete with physiologic cardiac remodeling from the athlete with cardiomyopathy.

Current problems in cardiology·2024
Same author

The diagnosis and treatment of women with recurrent cardiac ischemia and normal coronary arteries.

Current problems in cardiology·2023
Same author

Particulate Matter Air Pollution is a Significant Risk Factor for Cardiovascular Disease.

Current problems in cardiology·2023

Related Experiment Video

Updated: Jun 5, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cells in cardiac repair.

Robert J Henning1

  • 1James A. Haley VA Hospital/University of South Florida College of Medicine, Tampa, FL 33612, USA. robert.henning@va.gov

Future Cardiology
|December 23, 2010
PubMed
Summary

Stem cell therapy shows promise for heart attack recovery by regenerating damaged heart tissue. Research explores human embryonic stem cells, skeletal myoblasts, and bone marrow stem cells to improve heart function and limit damage.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) is a leading cause of death globally, with limited endogenous heart regeneration.
  • Current therapeutic strategies for MI focus on limiting infarct size and improving cardiac function.
  • Various stem cell types are being investigated for their potential in cardiac repair after MI.

Purpose of the Study:

  • To review the potential of different stem cell types, including human embryonic stem cells (hESCs), skeletal myoblasts, and bone marrow stem cells (BMSCs), for myocardial repair.
  • To identify challenges and future directions for cell-based cardiac repair strategies.

Main Methods:

  • Review of existing literature on stem cell transplantation in preclinical and clinical models of myocardial infarction.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 5, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

  • Analysis of the efficacy, limitations, and safety profiles of different stem cell types.
  • Discussion of key challenges including cell survival, immune rejection, and optimal delivery methods.

    • Main Results:

    • hESCs show potential for myocardial regeneration but pose risks like teratoma formation, necessitating differentiation into cardiac progenitor cells.
    • Skeletal myoblasts can improve left ventricle (LV) ejection fraction but may cause arrhythmias due to lack of electromechanical coupling.
    • Autologous bone marrow mononuclear cells have demonstrated significant improvements in LV ejection fraction and infarct size reduction without inducing arrhythmias, possibly via paracrine effects.

    Conclusions:

    • Cell-based cardiac repair holds significant promise for treating myocardial infarction and preventing heart failure.
    • Overcoming challenges such as cell survival, immune compatibility, and optimal delivery techniques is crucial for clinical translation.
    • Further research and clinical collaboration are essential to advance stem cell therapies for widespread application in cardiac repair.